Humacyte (HUMA) Net Long-Term Debt Issued (Repaid) (2020 - 2026)
Humacyte's Non-Current Debt came in at $17.67 million for Q3 2025, down 71.5% from $62.12 million a year earlier and down 73.4% from the prior quarter.
Powered by 
Analysis
Humacyte (HUMA) Net Long-Term Debt Issued (Repaid) (2020 - 2026) Analysis & Trends
At the end of FY2024, Humacyte's Non-Current Debt was $63.35 million, up 64.1% from FY2023.
- Non-Current Debt carries a four-year compound annual growth rate of 196.3% (FY2020 to FY2024).
- Going back by year, Non-Current Debt was $38.6 million in FY2023 (+89.8%), $20.34 million in FY2022 (-25.7%), $27.36 million in FY2021 and $822,000 in FY2020.
- The Q3 2025 figure represents the lowest quarterly Non-Current Debt since Q1 2023.
- Year-over-year, Non-Current Debt increased in seven of the last eight quarters, with growth averaging 61.3%.
- The fastest year-over-year change in Non-Current Debt over five years came in Q1 2024 (growth of 253.2%), and the weakest in Q3 2025 (a decline of 71.5%).
- Business Quant data shows HUMA's Non-Current Debt at $66.43 million (Q2 2025), $64.67 million (Q1 2025) and $63.35 million (Q4 2024) in the three quarters before Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net LT Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -1.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 9.98 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.91 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -3.05 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -19.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Humacyte | 163.90 Mn | -213.24 Mn | -401,000.00 | -177,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -177,000.00 |
| Jun 30, 2026 | -174,000.00 |
| Dec 31, 2025 | -38.42 Mn |
| Sep 30, 2025 | -50.74 Mn |
| Jun 30, 2025 | -727,000.00 |
| Mar 31, 2025 | -687,000.00 |
| Dec 31, 2024 | -673,000.00 |
| Jun 30, 2024 | -404,000.00 |
| Mar 31, 2024 | 19.40 Mn |
| Dec 31, 2023 | -588,000.00 |
| Sep 30, 2023 | -577,000.00 |
| Jun 30, 2023 | 7.39 Mn |
| Mar 31, 2023 | -528,000.00 |
| Jun 30, 2022 | -495,000.00 |
| Mar 31, 2022 | -462,000.00 |
| Dec 31, 2021 | 9.55 Mn |
| Sep 30, 2021 | -443,000.00 |
| Jun 30, 2021 | -432,000.00 |
| Mar 31, 2021 | 19.26 Mn |
| Dec 31, 2020 | -393,000.00 |
API Access
Humacyte Net Long-Term Debt Issued (Repaid) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=HUMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "HUMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=HUMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();